Ascendis Pharma
ASND
#1616
Rank
โ‚ฌ10.93 B
Marketcap
179,04ย โ‚ฌ
Share price
4.43%
Change (1 day)
40.09%
Change (1 year)

EPS for Ascendis Pharma (ASND)

EPS in 2025 (TTM): -3,86ย โ‚ฌ

According to Ascendis Pharma 's latest financial reports the company's current EPS (TTM) is -3,67ย โ‚ฌ. In 2024 the company made an earnings per share (EPS) of -6,06ย โ‚ฌ an increase over its 2023 EPS that were of -7,89ย โ‚ฌ.

EPS history for Ascendis Pharma from 2023 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-3,86ย โ‚ฌ-36.31%
2024-6,06ย โ‚ฌ-23.17%
2023-7,89ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Advaxis
ADXS
-8,25ย โ‚ฌ 125.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Affimed
AFMD
-4,45ย โ‚ฌ 21.47%๐Ÿ‡ฉ๐Ÿ‡ช Germany
Akebia Therapeutics
AKBA
-0,05963ย โ‚ฌ-98.37%๐Ÿ‡บ๐Ÿ‡ธ USA